Literature DB >> 17984212

Major congenital anomalies place extremely low birth weight infants at higher risk for poor growth and developmental outcomes.

Rachel V Walden1, Sarah C Taylor, Nellie I Hansen, W Kenneth Poole, Barbara J Stoll, Dianne Abuelo, Betty R Vohr.   

Abstract

BACKGROUND: Studies of growth and neurodevelopmental impairment in extremely low birth weight infants often exclude infants with major congenital anomalies; thus, there are few outcome data available on these infants.
OBJECTIVES: The purpose of this work was to compare growth and neurodevelopmental outcomes of extremely low birth weight infants with major anomalies to extremely low birth weight infants without these findings. It was hypothesized that infants with severe anomalies would have worse growth, neurodevelopmental, and survival outcomes.
METHODS: A retrospective cohort analysis was performed on 5920 extremely low birth weight infants surviving beyond 12 hours of life at 19 neonatal network centers between 1998 and 2001. Infants with significant anomalies were more likely to die before 18 to 22 months' corrected age. A total of 3705 children underwent neurodevelopmental and anthropometric evaluation at 18 to 22 months' corrected age. Statistical significance for unadjusted comparisons was determined by Wilcoxon tests for continuous variables and chi2 or Fisher's exact tests for categorical variables. Regression models were used to compare the outcomes after adjusting for potential confounders.
RESULTS: Children with major congenital anomalies were more likely to have Bayley Mental Development Index scores of < or = 70, Psychomotor Development Index scores of < or = 70, neurodevelopmental impairment, moderate-to-severe cerebral palsy, length in the < or = 10th percentile, head circumference in the < or = 10th percentile, more rehospitalizations, and higher rates of early intervention use at 18 to 22 months' corrected age.
CONCLUSIONS: At 18 to 22 months' corrected age, extremely low birth weight infants born with major anomalies have nearly twice the risk for neurodevelopmental impairment, increased risk of poor growth, and > 3 times greater risk of rehospitalization when compared with extremely low birth weight infants without major anomalies. This information may be valuable for counseling parents regarding the outcomes of these infants and for the facilitation of appropriate support and intervention services.

Entities:  

Mesh:

Year:  2007        PMID: 17984212     DOI: 10.1542/peds.2007-0354

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Early outcome of preterm infants with birth weight of 1500 g or less and gestational age of 30 weeks or less in Isfahan city, Iran.

Authors:  Fakhri Navaei; Banafsheh Aliabady; Javad Moghtaderi; Masoud Moghtaderi; Roya Kelishadi
Journal:  World J Pediatr       Date:  2010-06-12       Impact factor: 2.764

2.  A spectrum project: preterm birth and small-for-gestational age among infants with birth defects.

Authors:  F Miquel-Verges; B S Mosley; A S Block; C A Hobbs
Journal:  J Perinatol       Date:  2014-10-02       Impact factor: 2.521

Review 3.  Resuscitation decisions in fetal myelomeningocele repair should center on parents' values: a counter analysis.

Authors:  Stephanie K Kukora; Jessica T Fry
Journal:  J Perinatol       Date:  2022-04-07       Impact factor: 3.225

4.  Low birth weight of newborns: magnitude of the problem seen in a 100 bed hospital of a rural area in vellore district, Tamil Nadu (India).

Authors:  Kavitha Balaji; Sathish Sankar; Balaji Nandagopal
Journal:  Indian J Community Med       Date:  2010-04

5.  Postnatal screening and care for non-medical risk factors by preventive child healthcare in deprived and non-deprived neighbourhoods.

Authors:  M R C van Minde; S M Hulst; H Raat; E A P Steegers; M L A de Kroon
Journal:  BMC Health Serv Res       Date:  2018-06-08       Impact factor: 2.655

6.  Epigenome-wide Analysis Identifies Genes and Pathways Linked to Neurobehavioral Variation in Preterm Infants.

Authors:  Todd M Everson; Carmen J Marsit; T Michael O'Shea; Amber Burt; Karen Hermetz; Brian S Carter; Jennifer Helderman; Julie A Hofheimer; Elisabeth C McGowan; Charles R Neal; Steven L Pastyrnak; Lynne M Smith; Antoine Soliman; Sheri A DellaGrotta; Lynne M Dansereau; James F Padbury; Barry M Lester
Journal:  Sci Rep       Date:  2019-04-19       Impact factor: 4.996

7.  Association of Abnormal Findings on Neonatal Cranial Ultrasound With Neurobehavior at Neonatal Intensive Care Unit Discharge in Infants Born Before 30 Weeks' Gestation.

Authors:  Jennifer Helderman; T Michael O'Shea; Lynne Dansereau; Jennifer Check; Julie A Hofheimer; Lynne M Smith; Elisabeth McGowan; Charles R Neal; Brian S Carter; Steven L Pastyrnak; Bradford Betz; Joseph Junewick; Heather L Borders; Sheri A DellaGrotta; Barry M Lester
Journal:  JAMA Netw Open       Date:  2022-04-01

8.  Survival rate of extremely low birth weight infants and its risk factors: case-control study in Japan.

Authors:  Masaki Ogawa; Yoshio Matsuda; Eriko Kanda; Jun Konno; Minoru Mitani; Yasuo Makino; Hideo Matsui
Journal:  ISRN Obstet Gynecol       Date:  2013-11-25

9.  Serious neonatal morbidities are associated with differences in DNA methylation among very preterm infants.

Authors:  Todd M Everson; T Michael O'Shea; Amber Burt; Karen Hermetz; Brian S Carter; Jennifer Helderman; Julie A Hofheimer; Elisabeth C McGowan; Charles R Neal; Steven L Pastyrnak; Lynne M Smith; Antoine Soliman; Sheri A DellaGrotta; Lynne M Dansereau; James F Padbury; Barry M Lester; Carmen J Marsit
Journal:  Clin Epigenetics       Date:  2020-10-19       Impact factor: 7.259

10.  Prenatal risk factors and neonatal DNA methylation in very preterm infants.

Authors:  Marie Camerota; Stefan Graw; Todd M Everson; Elisabeth C McGowan; Julie A Hofheimer; T Michael O'Shea; Brian S Carter; Jennifer B Helderman; Jennifer Check; Charles R Neal; Steven L Pastyrnak; Lynne M Smith; Lynne M Dansereau; Sheri A DellaGrotta; Carmen J Marsit; Barry M Lester
Journal:  Clin Epigenetics       Date:  2021-09-10       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.